Physician profile
Peter E Zambito
NPI 1497978456
$2,979.42
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $169 · 2021: $170 · 2022: $79.79 · 2023: $1,290 · 2024: $37.78 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $966 · Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $965.71 |
| Food and Beverage | $477.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,336.17 | 2021-2023 | Micra |
| Amgen INC. | $444.92 | 2019-2025 | Repatha |
| Boston Scientific Corporation | $293.05 | 2019-2025 | General - Therapies, Emblem Mri S-Icd |
| Sanofi-Aventis U.S. LLC | $198.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $133.25 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $131.67 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $91.98 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $75.34 | 2019-2024 | Camzyos |
| Abbott Laboratories | $54.10 | 2019 | |
| Pfizer INC. | $40.12 | 2019 | |
| Merck Sharp & Dohme LLC | $21.20 | 2024 | Verquvo |
| Cardiva Medical, INC. | $20.34 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Astrazeneca Pharmaceuticals Lp | $18.75 | 2019 | |
| Cvrx, INC. | $7.62 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Zambito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.